Seznam kandidatnih snovi, ki vzbujajo veliko zaskrbljenost in za katere je treba pridobiti avtorizacijo
Seznam kandidatnih snovi, ki vzbujajo veliko zaskrbljenost in za katere je treba pridobiti avtorizacijo
(Objavljeno v skladu s členom 59(10) uredbe REACH)
Seznam kandidatnih snovi, ki vzbujajo veliko zaskrbljenost in za katere je treba pridobiti avtorizacijo
Opombe:
- Izvirna različica: kot izviren se šteje le seznam kandidatnih snovi, objavljen na tej spletni strani. Ob vključitvi snovi na seznam kandidatnih snovi na tej spletni strani lahko pričnejo za podjetja takoj veljati pravne obveznosti, zlasti tiste iz členov 7, 31 in 33 uredbe REACH.
- Numerične oznake: vsak vpis na seznam kandidatnih snovi zajema brezvodne in hidrirane oblike snovi. Številka CAS v vpisu se običajno nanaša na brezvodno obliko. Hidrirane oblike snovi, označene z drugimi številkami CAS, spadajo tudi med vpise na seznam kandidatnih snovi.
- Druge numerične oznake: za vpise z oznako „-“ v stolpcu za številko ES in CAS je na voljo neizčrpen seznam registracijskih številk ES in/ali CAS, ki se nanašajo na snovi ali skupine snovi, ki spadajo med vpise na seznam kandidatnih snovi, če je to v praksi mogoče. Te informacije so na voljo s klikom na gumb „Podrobnosti" ob izbranem vpisu.
Filter the list
The List does not contain any Substances.
Odločba | Nabor podatkov IUCLID | ||||||
---|---|---|---|---|---|---|---|
206-203-2
|
307-55-1
|
19-dec.-2012
|
vPvB (Article 57e) |
Details | |||
262-967-7
|
61788-32-7
|
27-jun.-2018
|
vPvB (Article 57e) |
Details | |||
473-390-7
|
-
|
17-jan.-2023
|
vPvB (Article 57e) |
Details | |||
204-927-3
|
129-00-0
|
15-jan.-2019
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
-
|
266-028-2
|
65996-93-2
|
13-jan.-2010
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
201-581-5
|
85-01-8
|
15-jan.-2019
|
vPvB (Article 57e) |
Details | |||
PFHxS
show/hide
tridecafluorohexanesulphonic acid, compound with 2,2'-iminodiethanol (1:1)
Št. ES :
274-462-9
| Št. CAS:
70225-16-0
Phosphonium, triphenyl(phenylmethyl)-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Št. ES :
-
| Št. CAS:
1000597-52-3
Ethanaminium, N-[4-[[4-(diethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Št. ES :
-
| Št. CAS:
1310480-24-0
Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Št. ES :
-
| Št. CAS:
1310480-27-3
Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(phenylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Št. ES :
-
| Št. CAS:
1310480-28-4
Beta-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1)
Št. ES :
-
| Št. CAS:
1329995-45-0
Gamma-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1)
Št. ES :
-
| Št. CAS:
1329995-69-8
Sulfonium, triphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Št. ES :
-
| Št. CAS:
144116-10-9
Quinolinium, 1-(carboxymethyl)-4-[2-[4-[4-(2,2-diphenylethenyl)phenyl]-1,2,3,3a,4,8b-hexahydrocyclopent[b]indol-7-yl]ethenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Št. ES :
-
| Št. CAS:
1462414-59-0
Iodonium, diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Št. ES :
-
| Št. CAS:
153443-35-7
Methanaminium, N,N,N-trimethyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1)
Št. ES :
-
| Št. CAS:
189274-31-5
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd.with 2-methyl-2-propanamine (1:1)
Št. ES :
-
| Št. CAS:
202189-84-2
Iodonium, bis[4-(1,1-dimethylethyl)phenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Št. ES :
-
| Št. CAS:
213740-81-9
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, gallium salt (9CI)
Št. ES :
-
| Št. CAS:
341035-71-0
Sulfonium, bis(4-methylphenyl)phenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Št. ES :
-
| Št. CAS:
341548-85-4
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, scandium(3+) salt (3:1)
Št. ES :
-
| Št. CAS:
350836-93-0
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, neodymium(3+) salt (3:1)
Št. ES :
-
| Št. CAS:
41184-65-0
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, yttrium(3+) salt (3:1)
Št. ES :
-
| Št. CAS:
41242-12-0
Sulfonium, (thiodi-4,1-phenylene)bis[diphenyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:2)
Št. ES :
-
| Št. CAS:
421555-73-9
Iodonium, bis[4-(1,1-dimethylpropyl)phenyl]-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic
Št. ES :
-
| Št. CAS:
421555-74-0
Sulfonium, tris[4-(1,1-dimethylethyl)phenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Št. ES :
-
| Št. CAS:
425670-70-8
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, lithium salt (1:1)
Št. ES :
-
| Št. CAS:
55120-77-9
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, zinc salt
Št. ES :
-
| Št. CAS:
70136-72-0
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. with N,N-diethylethanamine (1:1)
Št. ES :
-
| Št. CAS:
72033-41-1
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, sodium salt
Št. ES :
-
| Št. CAS:
82382-12-5
Iodonium, bis[(1,1-dimethylethyl)phenyl]-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1) (9CI)
Št. ES :
-
| Št. CAS:
866621-50-3
Sulfonium, (4-methylphenyl)diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Št. ES :
-
| Št. CAS:
910606-39-2
Sulfonium, [4-[(2-methyl-1-oxo-2-propen-1-yl)oxy]phenyl]diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Št. ES :
-
| Št. CAS:
911027-68-4
Dibenzo[k,n][1,4,7,10,13]tetraoxathiacyclopentadecinium, 19-[4-(1,1-dimethylethyl)phenyl]-6,7,9,10,12,13-hexahydro-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Št. ES :
-
| Št. CAS:
928049-42-7
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, cesium salt (1:1)
Št. ES :
-
| Št. CAS:
92011-17-1
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. With pyrrolidine (1:1)
Št. ES :
-
| Št. CAS:
1187817-57-7
|
-
|
-
|
07-jul.-2017
|
vPvB (Article 57e) |
Details | ||
show/hide
|
-
|
-
|
17-jan.-2023
|
Toxic for reproduction (Article 57c) PBT (Article 57d) vPvB (Article 57e) Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | ||
276-745-2
|
72629-94-8
|
19-dec.-2012
|
vPvB (Article 57e) |
Details | |||
show/hide
|
700-960-7
|
-
|
23-jan.-2024
|
vPvB (Article 57e) |
Details | ||
D4
|
209-136-7
|
556-67-2
|
27-jun.-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
UVCB substances consisting of more than or equal to 80% linear chloroalkanes with carbon chain lengths within the range from C14 to C17
show/hide
|
-
|
-
|
08-jul.-2021
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
206-803-4
|
376-06-7
|
19-dec.-2012
|
vPvB (Article 57e) |
Details | |||
218-165-4
|
2058-94-8
|
19-dec.-2012
|
vPvB (Article 57e) |
Details | |||
205-912-4
|
206-44-0
|
15-jan.-2019
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
D6
|
208-762-8
|
540-97-6
|
27-jun.-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
D5
|
208-764-9
|
541-02-6
|
27-jun.-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
205-923-4
|
218-01-9
|
15-jan.-2018
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
223-445-4
|
3896-11-5
|
23-jan.-2024
|
vPvB (Article 57e) |
Details | |||
214-604-9
|
1163-19-5
|
19-dec.-2012
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
201-247-9
|
80-07-9
|
14-jun.-2023
|
vPvB (Article 57e) |
Details | |||
show/hide
|
-
|
-
|
17-jan.-2023
|
vPvB (Article 57e) |
Details | ||
205-916-6
|
207-08-9
|
15-jan.-2019
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
205-883-8
|
191-24-2
|
27-jun.-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
200-028-5
|
50-32-8
|
20-jun.-2016
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
200-280-6
|
56-55-3
|
15-jan.-2018
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
-
|
292-604-8
|
90640-82-7
|
13-jan.-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
-
|
295-278-5
|
91995-17-4
|
13-jan.-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
-
|
295-275-9
|
91995-15-2
|
13-jan.-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
-
|
292-603-2
|
90640-81-6
|
13-jan.-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
-
|
292-602-7
|
90640-80-5
|
13-jan.-2010
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
287-476-5
|
85535-84-8
|
28-okt.-2008
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
201-329-4
|
81-15-2
|
28-okt.-2008
|
vPvB (Article 57e) |
Details | |||
covering any of the individual stereoisomers of [1] and [2] or any combination thereof
show/hide
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Št. ES :
-
| Št. CAS:
676367-06-9
Reaction mass of 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane
Št. ES :
413-720-9
| Št. CAS:
-
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
Št. ES :
-
| Št. CAS:
117933-89-8
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
Št. ES :
-
| Št. CAS:
186309-28-4
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Št. ES :
-
| Št. CAS:
676367-05-8
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-rel-
Št. ES :
-
| Št. CAS:
343934-04-3
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Št. ES :
-
| Št. CAS:
676367-09-2
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-rel-
Št. ES :
-
| Št. CAS:
343934-05-4
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Št. ES :
-
| Št. CAS:
676367-04-7
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Št. ES :
-
| Št. CAS:
676367-08-1
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Št. ES :
-
| Št. CAS:
676367-03-6
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Št. ES :
-
| Št. CAS:
676367-07-0
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Št. ES :
-
| Št. CAS:
676367-02-5
|
-
|
-
|
15-jun.-2015
|
vPvB (Article 57e) |
Details | ||
223-346-6
|
3846-71-7
|
17-dec.-2014
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
253-037-1
|
36437-37-3
|
17-dec.-2015
|
vPvB (Article 57e) |
Details | |||
221-573-5
|
3147-75-9
|
23-jan.-2024
|
vPvB (Article 57e) |
Details | |||
247-384-8
|
25973-55-1
|
17-dec.-2014
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
223-383-8
|
3864-99-1
|
17-dec.-2015
|
vPvB (Article 57e) |
Details | |||
covering any of its individual anti- and syn-isomers or any combination thereof
show/hide
(1S,2S,5R,6R,9S,10S,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
Št. ES :
-
| Št. CAS:
135821-03-3
(1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
Št. ES :
-
| Št. CAS:
135821-74-8
1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene
Št. ES :
236-948-9
| Št. CAS:
13560-89-9
|
-
|
-
|
15-jan.-2018
|
vPvB (Article 57e) |
Details | ||
253-692-3
|
37853-59-1
|
17-jan.-2023
|
vPvB (Article 57e) |
Details | |||
246-677-8
|
25155-23-1
|
16-dec.-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
213-934-0
|
1067-53-4
|
17-jan.-2022
|
Toxic for reproduction (Article 57c) |
Details | |||
204-118-5
|
115-96-8
|
13-jan.-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
235-252-2
|
12141-20-7
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
222-979-5
|
3687-31-8
|
19-dec.-2011
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
215-290-6
|
1319-46-6
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
235-380-9
|
12202-17-4
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
201-075-4
|
78-00-2
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
235-541-3
|
12267-73-1
|
18-jun.-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
263-467-1
|
62229-08-7
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
231-556-4
|
7632-04-4
|
16-jun.-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
Borate(2-), tetrahydroxybis[μ-(peroxy-κO1:κO2)]di-, sodium, hydrate (1:2:6)
Št. ES :
-
| Št. CAS:
125022-34-6
|
-
|
-
|
16-jun.-2014
|
Toxic for reproduction (Article 57c) |
Details | ||
234-190-3
|
10588-01-9, 7789-12-0
|
28-okt.-2008
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |||
231-889-5
|
7775-11-3
|
18-jun.-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |||
234-363-3
|
11120-22-2
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
with lead (Pb) content above the applicable generic concentration limit for ’toxicity for reproduction’ Repr. 1A (CLP) or category 1 (DSD),the substance is a member of the group entry of lead compounds, with index number 082-001-00-6 in Regulation (EC) No 1272/2008
|
272-271-5
|
68784-75-8
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | ||
-
|
-
|
17-dec.-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
232-382-1
|
8012-00-8
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | ||
231-906-6
|
7778-50-9
|
18-jun.-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
-
|
-
|
08-jul.-2021
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
show/hide
|
-
|
-
|
17-dec.-2015
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | ||
235-067-7
|
12065-90-6
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
206-397-9
|
335-67-1
|
20-jun.-2013
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | |||
show/hide
|
-
|
-
|
08-jul.-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
215-235-6
|
1314-41-6
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
-
|
-
|
12-jan.-2017
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | ||
202-716-0
|
98-95-3
|
17-dec.-2015
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
776297-69-9
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
201-182-6
|
79-16-3
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
200-679-5
|
68-12-2
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
204-826-4
|
127-19-5
|
19-dec.-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
210-894-6
|
625-45-6
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
401-750-5
|
17570-76-2
|
18-jun.-2012
|
Toxic for reproduction (Article 57c) |
Details | ||
235-727-4
|
12626-81-2
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
235-038-9
|
12060-00-3
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
215-693-7
|
1344-37-2
|
13-jan.-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | ||
239-290-0
|
15245-44-0
|
19-dec.-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
234-853-7
|
12036-76-9
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
215-267-0
|
1317-36-8
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
232-064-2
|
7784-40-9
|
28-okt.-2008
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
229-335-2
|
6477-64-1
|
19-dec.-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
233-245-9
|
10099-74-8
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
236-542-1
|
13424-46-9
|
19-dec.-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
206-104-4
|
301-04-2
|
16-dec.-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
244-073-9
|
20837-86-9
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
235-759-9
|
12656-85-8
|
13-jan.-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | ||
231-846-0
|
7758-97-6
|
13-jan.-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
237-486-0
|
13814-96-5
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
231-100-4
|
7439-92-1
|
27-jun.-2018
|
Toxic for reproduction (Article 57c) |
Details | |||
202-506-9
|
96-45-7
|
16-dec.-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
200-842-0
|
75-12-7
|
18-jun.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
292-966-7
|
91031-62-8
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
215-540-4
|
12179-04-3, 1303-96-4, 1330-43-4
|
18-jun.-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
234-541-0
|
12008-41-2
|
27-jun.-2018
|
Toxic for reproduction (Article 57c) |
Details | |||
278-355-8
|
75980-60-8
|
14-jun.-2023
|
Toxic for reproduction (Article 57c) |
Details | |||
205-017-9
|
131-18-0
|
20-jun.-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
235-702-8
|
12578-12-0
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
-
|
-
|
19-jan.-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
201-861-7
|
88-85-7
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
210-088-4
|
605-50-5
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
276-090-2
|
71850-09-4
|
16-jan.-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
201-553-2
|
84-69-5
|
13-jan.-2010
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
201-559-5
|
84-75-3
|
16-dec.-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
DCHP
|
201-545-9
|
84-61-7
|
27-jun.-2018
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
211-670-0
|
683-18-1
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
245-152-0
|
22673-19-4
|
25-jun.-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
201-557-4
|
84-74-2
|
28-okt.-2008
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
215-125-8
|
1303-86-2
|
18-jun.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
233-334-2
|
10124-43-3
|
15-dec.-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
233-402-1
|
10141-05-6
|
15-dec.-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
200-755-8
|
71-48-7
|
15-dec.-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
208-169-4
|
513-79-1
|
15-dec.-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
231-589-4
|
7646-79-9
|
28-okt.-2008
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
233-331-6
|
10124-36-4, 31119-53-6
|
17-dec.-2014
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | ||
232-222-0
|
7790-79-6
|
17-dec.-2014
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
show/hide
|
233-296-7
|
10108-64-2
|
16-jun.-2014
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | ||
EC No. 233-139-2 and EC No. 234-343-4
show/hide
|
-
|
-
|
18-jun.-2010
|
Toxic for reproduction (Article 57c) |
Details | ||
204-212-6
|
117-82-8
|
19-dec.-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
203-924-4
|
111-96-6
|
19-dec.-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
205-594-7
|
143-24-8
|
19-jan.-2021
|
Toxic for reproduction (Article 57c) |
Details | |||
204-211-0
|
117-81-7
|
28-okt.-2008
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
201-622-7
|
85-68-7
|
28-okt.-2008
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
237-222-4
|
13701-59-2
|
17-jan.-2023
|
Toxic for reproduction (Article 57c) |
Details | |||
223-320-4
|
3825-26-1
|
20-jun.-2013
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | |||
232-143-1
|
7789-09-5
|
18-jun.-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |||
257-175-3
|
51404-69-4
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
273-688-5
|
69011-06-9
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
204-327-1
|
119-47-1
|
17-jan.-2022
|
Toxic for reproduction (Article 57c) |
Details | |||
201-250-5
|
80-09-1
|
17-jan.-2023
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
Bisphenol A; BPA
|
201-245-8
|
80-05-7
|
12-jan.-2017
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
ZOLDINE MS-PLUS
|
421-150-7
|
143860-04-2
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | ||
211-765-7
|
693-98-1
|
25-jun.-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97
|
400-600-6
|
71868-10-5
|
16-jan.-2020
|
Toxic for reproduction (Article 57c) |
Details | ||
203-772-9
|
110-49-6
|
16-jul.-2019
|
Toxic for reproduction (Article 57c) |
Details | |||
203-713-7
|
109-86-4
|
15-dec.-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
239-622-4
|
15571-58-1
|
17-dec.-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
203-839-2
|
111-15-9
|
20-jun.-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
203-804-1
|
110-80-5
|
15-dec.-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
CG 25-369; IRGACURE 369; TK 11-319
|
404-360-3
|
119313-12-1
|
16-jan.-2020
|
Toxic for reproduction (Article 57c) |
Details | ||
438-340-0
|
119344-86-4
|
23-jan.-2024
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
-
|
-
|
08-jul.-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
211-989-5
|
732-26-3
|
23-jan.-2024
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | |||
AP-5
|
401-720-1
|
6807-17-6
|
15-jan.-2019
|
Toxic for reproduction (Article 57c) |
Details | ||
214-012-0
|
1072-63-5
|
25-jun.-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
212-828-1
|
872-50-4
|
20-jun.-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
203-445-0
|
106-94-5
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
211-076-1
|
629-14-1
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
203-977-3
|
112-49-2
|
18-jun.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
284-032-2
|
84777-06-0
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
271-093-5
|
68515-50-4
|
16-jun.-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
271-084-6
|
68515-42-4
|
20-jun.-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
276-158-1
|
71888-89-6
|
20-jun.-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5)
show/hide
1,2-Benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters
Št. ES :
272-013-1
| Št. CAS:
68648-93-1
|
-
|
-
|
15-jun.-2015
|
Toxic for reproduction (Article 57c) |
Details | ||
202-486-1
|
96-18-4
|
20-jun.-2011
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
203-794-9
|
110-71-4
|
18-jun.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
215-147-8
|
1306-23-6
|
16-dec.-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
show/hide
|
215-146-2
|
1306-19-0
|
20-jun.-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | ||
233-710-6
|
10325-94-7
|
15-jan.-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
244-168-5
|
21041-95-2
|
15-jan.-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
208-168-9
|
513-78-0
|
15-jan.-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
231-152-8
|
7440-43-9
|
20-jun.-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
including cis- and trans- stereo isomeric forms and all possible combinations of the isomers
show/hide
|
-
|
-
|
19-dec.-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
203-856-5
|
111-30-8
|
08-jul.-2021
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | |||
EDA
|
203-468-6
|
107-15-3
|
27-jun.-2018
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
204-650-8
|
123-77-3
|
19-dec.-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | |||
all possible combinations of the cis- and trans-isomers
show/hide
|
-
|
-
|
19-dec.-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
trimellitic anhydride; TMA
|
209-008-0
|
552-30-7
|
27-jun.-2018
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
X4261
|
401-850-9
|
255881-94-8
|
17-jan.-2022
|
PBT (Article 57d) |
Details | ||
and all major diastereoisomers identified
show/hide
|
-
|
-
|
28-okt.-2008
|
PBT (Article 57d) |
Details | ||
200-268-0
|
56-35-9
|
28-okt.-2008
|
PBT (Article 57d) |
Details | |||
204-371-1
|
120-12-7
|
28-okt.-2008
|
PBT (Article 57d) |
Details | |||
232-140-5
|
7789-00-6
|
18-jun.-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
213-103-2
|
924-42-5
|
10-jun.-2022
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
200-879-2
|
75-56-9
|
19-dec.-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
200-589-6
|
64-67-5
|
19-dec.-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
215-607-8
|
1333-82-0
|
15-dec.-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
201-173-7
|
79-06-1
|
30-mar.-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
show/hide
|
-
|
-
|
19-dec.-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | ||
-
|
423-400-0
|
59653-74-6
|
18-jun.-2012
|
Mutagenic (Article 57b) |
Details | ||
219-514-3
|
2451-62-9
|
18-jun.-2012
|
Mutagenic (Article 57b) |
Details | |||
show/hide
1-(4-butoxy-1-naphthalenyl)tetrahydrothiophenium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfonate
Št. ES :
468-770-4
| Št. CAS:
-
N,N,N-triethylethanaminium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate
Št. ES :
-
| Št. CAS:
25628-08-4
|
-
|
-
|
16-jan.-2020
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | ||
203-615-4
|
108-78-1
|
17-jan.-2023
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | |||
covering any of their individual isomers and combinations thereof
show/hide
2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionyl fluoride
Št. ES :
218-173-8
| Št. CAS:
2062-98-8
potassium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionate
Št. ES :
266-578-3
| Št. CAS:
67118-55-2
|
-
|
-
|
16-jul.-2019
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | ||
204-661-8
|
123-91-1
|
08-jul.-2021
|
Carcinogenic (Article 57a) Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | |||
224-208-8
|
4247-02-3
|
17-jan.-2023
|
Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
202-318-7
|
94-26-8
|
25-jun.-2020
|
Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
201-025-1
|
77-40-7
|
08-jul.-2021
|
Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
show/hide
(±)-1,7,7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one
Št. ES :
253-242-6
| Št. CAS:
36861-47-9
(3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Št. ES :
-
| Št. CAS:
1782069-81-1
(1R,3E,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Št. ES :
-
| Št. CAS:
95342-41-9
(1S,3E,4R)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Št. ES :
-
| Št. CAS:
852541-30-1
(1R,3Z,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Št. ES :
-
| Št. CAS:
852541-21-0
(1R,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Št. ES :
-
| Št. CAS:
741687-98-9
(1S,3Z,4R)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Št. ES :
-
| Št. CAS:
852541-25-4
|
-
|
-
|
17-jan.-2022
|
Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
show/hide
|
-
|
-
|
16-jul.-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl)
show/hide
Reaction product of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and phenol, heptyl derivs.
Št. ES :
-
| Št. CAS:
1471311-26-8
Formaldehyde, reaction products with branched and linear heptylphenol, carbon disulfide and hydrazine
Št. ES :
300-298-5
| Št. CAS:
93925-00-9
|
-
|
-
|
15-jan.-2018
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
201-280-9
|
80-46-6
|
12-jan.-2017
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
202-679-0
|
98-54-4
|
16-jul.-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, ethoxylated covering UVCB- and well-defined substances, polymers and homologues, which include any of the individual isomers and/or combinations thereof
show/hide
Nonylphenol, branched, ethoxylated
1 - 2.5 moles ethoxylated
Št. ES :
500-209-1
| Št. CAS:
68412-54-4
44-(nonylphenoxy)-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontanol
Št. ES :
260-678-0
| Št. CAS:
57321-10-5
4-Nonylphenol, branched, ethoxylated
1 - 2.5 moles ethoxylated
Št. ES :
500-315-8
| Št. CAS:
127087-87-0
3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(isononylphenoxy)-
Št. ES :
-
| Št. CAS:
65455-72-3
29-(nonylphenoxy)-3,6,9,12,15,18,21,24,27-nonaoxanonacosanol
Št. ES :
248-294-1
| Št. CAS:
27177-08-8
26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol
Št. ES :
247-816-5
| Št. CAS:
26571-11-9
26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol;
Št. ES :
255-695-5
| Št. CAS:
42173-90-0
3,6,9,12-Tetraoxatetradecan-1-ol, 14-(4-nonylphenoxy)-, branched
Št. ES :
293-926-1
| Št. CAS:
91648-64-5
|
799-990-1
|
-
|
20-jun.-2013
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
show/hide
|
-
|
-
|
19-dec.-2012
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
substances with a linear and/or branched alkyl chain with a carbon number of 7 covalently bound predominantly in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
show/hide
|
-
|
-
|
12-jan.-2017
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
covering well-defined substances and UVCB substances, polymers and homologues
show/hide
Poly(oxy-1,2-ethanediyl), α-[(1,1,3,3-tetramethylbutyl)phenyl]-ω-hydroxy-
Št. ES :
-
| Št. CAS:
9036-19-5
20-[4-(1,1,3,3-tetramethylbutyl)phenoxy]-3,6,9,12,15,18-hexaoxaicosan-1-ol
Št. ES :
219-682-8
| Št. CAS:
2497-59-8
|
-
|
-
|
19-dec.-2012
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
205-426-2
|
140-66-9
|
19-dec.-2011
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
3-benzylidene camphor; 3-BC
|
239-139-9
|
15087-24-8
|
15-jan.-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
229-851-8
|
6786-83-0
|
18-jun.-2012
|
Carcinogenic (Article 57a) |
Details | ||